Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Bayer Plc Bayer House Strawberry Hill Newbury Berkshire RG14 1JA United Kingdom
Ciproxin 250 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Round, nearly white to slightly yellowish tablets marked with “CIP score 250” on one side and a Bayer cross on the reverse side. The tablets can be divided into equal halves. |
Each film-coated tablet contains 250 mg ciprofloxacin (as hydrochloride).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ciprofloxacin |
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Tablet core: Cellulose microcrystalline Film-coat: Hypromellose |
One of the following primary packaging materials is used:
Pack sizes of: 6, 8, 10, 12, 14, 16, 20, 28, 50, 100, 160 or 500 film-coated tablets.
Not all pack sizes may be marketed.
Bayer Plc
Bayer House
Strawberry Hill
Newbury
Berkshire RG14 1JA
United Kingdom
PL 00010/0146
3 February 1987 / 9 October 2010
| Drug | Countries | |
|---|---|---|
| CIPROXIN | Austria, Cyprus, Finland, Hong Kong, Ireland, Italy, Malta, Netherlands, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
